SLC5A2 and hydrops fetalis: In a study by Bode et al., the dual inhibition of sodium–glucose linked transporters type 1 and 2 (SGLT-1 and SGLT-2) with sotagliflozin improved left atrial (LA) dysfunction in a metabolic syndrome-related rat model of HF with preserved ejection fraction (HFpEF) [26].